Dr. Saumilkumar Karavadia, MD
What this data tells you about Dr. Karavadia
Dr. Saumilkumar Karavadia is an urology physician in Oxford, FL, with 18 years in practice. Based on federal Medicare data, Dr. Karavadia performed 17,006 Medicare services across 5,686 unique beneficiaries.
Between the years covered by Open Payments, Dr. Karavadia received a total of $47,763 from 62 pharmaceutical and/or device companies across 590 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Karavadia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 3,501 | $0 | $1 |
| BCG treatment for bladder cancer | 3,250 | $2 | $5 |
| Automated urinalysis | 2,563 | $2 | $5 |
| Office visit, established patient (30-39 min) | 1,678 | $92 | $320 |
| Leuprolide injectable, camcevi, 1 mg | 966 | $68 | $130 |
| Bladder ultrasound after voiding | 879 | $8 | $26 |
| Blood draw (venipuncture) | 809 | $6 | $6 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 747 | $1 | $3 |
| Office visit, established patient (20-29 min) | 635 | $64 | $227 |
| Chronic care management, first 20 min/month | 379 | $47 | $159 |
| New patient office visit (45-59 min) | 249 | $117 | $422 |
| X-ray of abdomen, 1 view | 247 | $21 | $60 |
| Diagnostic exam of bladder and urethra using an endoscope | 210 | $61 | $610 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 161 | $136 | $336 |
| Instillation of anti-cancer drug into bladder | 78 | $64 | $219 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 76 | $24 | $81 |
| Simple insertion of temporary bladder tube | 55 | $44 | $156 |
| Mri scan of pelvis before and after contrast | 48 | $125 | $354 |
| Ct scan of abdomen and pelvis without contrast | 48 | $76 | $216 |
| Mri scan of abdomen before and after contrast | 46 | $147 | $386 |
| Ct scan of abdomen and pelvis before and after contrast | 42 | $195 | $527 |
| Insertion of stent in ureter using an endoscope | 37 | $134 | $599 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 36 | $115 | $809 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 34 | $325 | $1,061 |
| Hospital follow-up visit, moderate complexity | 30 | $64 | $179 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $16 | $57 |
| Initial hospital admission, moderate complexity | 27 | $104 | $341 |
| Shock wave crushing of kidney stones | 26 | $443 | $1,460 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 22 | $584 | $1,866 |
| Ultrasound scan of pelvic region through rectum | 20 | $26 | $93 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 18 | $223 | $735 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $138 | $992 |
| Biopsy of prostate gland | 16 | $106 | $612 |
| New patient office visit (30-44 min) | 15 | $87 | $283 |
| Dilation of urethra using an endoscope | 13 | $118 | $798 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for urology physician in FL.
Geographic Context
12.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Karavadia is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (speaking/promotional, top 6%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Karavadia experienced with contrast dye for imaging (iodine-based)?
Does Dr. Karavadia receive payments from pharmaceutical companies?
How do Dr. Karavadia's costs compare to other urology physicians in Oxford?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology